Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China-Reference-Cited by-同舟云学术

Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China

Published:2020-05-03 Issue:9 Volume:146 Page:2369-2378
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Zang Jian,Xu Man,Li Chen,Zhao Lina,Luo Shanuan,Wang Jianhua,Shi Mei^ORCID

Funder

Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-020-03229-3.pdf

Reference26 articles.

1. Chen Y et al (2008) Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. Int J Radiat Oncol Biol Phys 71:1356–1364. https://doi.org/10.1016/j.ijrobp.2007.12.028

2. Chen X et al (2014) Concurrent chemoradiotherapy comparison of taxanes and platinum versus 5-fluorouracil and platinum in nasopharyngeal carcinoma treatment. Chin Med J 127:142–149

3. Cheung F, Chan O, Ng WT, Chan L, Lee A, Pang SW (2012) The prognostic value of histological typing in nasopharyngeal carcinoma. Oral Oncol 48:429–433. https://doi.org/10.1016/j.oraloncology.2011.11.017

4. Ghosh-Laskar S et al (2019) Taxane-based Induction Chemotherapy Plus Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma: Prospective Results from a Non-endemic Cohort. Clin Oncol. https://doi.org/10.1016/j.clon.2019.06.011(Royal College of Radiologists [Great Britain])

5. Han F et al (2012) Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol 24:569–576. https://doi.org/10.1016/j.clon.2011.11.010(Royal College of Radiologists [Great Britain])

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing long-term efficacy and safety of GP versus TPF sequential chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis;BMC Cancer;2024-09-13

2. Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma;Drug Design, Development and Therapy;2023-02

3. Optimal induction chemotherapy regimen for locoregionally advanced nasopharyngeal carcinoma: an update Bayesian network meta-analysis;European Archives of Oto-Rhino-Laryngology;2022-06-29

4. The efficacy and safety of concurrent chemoradiotherapy with induction chemotherapy vs. concurrent chemoradiotherapy alone for locally advanced nasopharyngeal carcinoma: a systematic-review and meta-analysis;Translational Cancer Research;2022-05

5. Gemcitabine Versus Docetaxel Plus Cisplatin as Induction Chemotherapy in Nasopharyngeal Carcinoma;The Laryngoscope;2022-03-03